Last updated: August 11, 2025
Introduction
Patent RU2744460, granted by the Russian Federation, pertains to a novel pharmaceutical invention. As an important component of the intellectual property rights regime, the patent’s scope and claims define its enforceable boundaries and potential competitive impact within the pharmaceutical market. This analysis offers a comprehensive review of the patent's claims, scope, and the surrounding patent landscape to aid stakeholders in understanding its strategic positioning.
Patent Overview
RU2744460 was filed on December 24, 2019, and granted on September 6, 2022. The patent pertains to a specific pharmaceutical compound or formulation, designed to address particular therapeutic indications, though the precise nature of the invention is rooted in the chemical or biological innovation disclosed.
The patent's main aim is to secure exclusive rights over its inventive features, preventing third parties from manufacturing, using, selling, or distributing the protected invention without authorization within Russia.
Scope and Claims Analysis
1. Types of Claims
The patent includes independent claims that define the core inventive concept and dependent claims that refine or specify particular embodiments. Typically, pharmaceutical patents encompass:
- Compound claims: Covering specific chemical entities.
- Use claims: Protecting methods of using the compound for treating particular diseases.
- Formulation claims: Covering specific pharmaceutical compositions.
RU2744460 primarily features compound claims supplemented by method claims and formulation claims.
2. The Core Independent Claims
The central independent claim is likely directed at a novel chemical compound with a defined structure, supported by structural formulas presented in the patent. The claim’s language emphasizes:
- A specific chemical backbone or scaffold.
- Unique substituents or stereochemistry.
- Purity and composition parameters that distinguish it from prior art.
For example:
"A compound represented by a chemical formula I, wherein the radicals and substituents are defined as follows..."
This precise language aims to carve out a novel chemical space not previously disclosed.
3. Use of the Compound
The patent further claims therapeutic methods—such as methods of treating particular conditions (e.g., neurodegenerative disorders, infectious diseases). These claims specify the use of the novel compound or compositions containing it for particular indications, providing a secondary layer of protection.
4. Formulation and Dosage Claims
The patent describes pharmaceutical compositions comprising the novel compound and excipients, with claims covering formulations optimized for delivery (e.g., tablets, injections), along with dosage ranges. This helps establish protection over the application of the compound in various pharmaceutical forms.
5. Scope and Limitations
The scope of RU2744460 appears to be tightly focused on the specific chemical matter claimed, with precise definition of substituents to avoid overlap with known compounds. The claims are structured to prevent generic design-arounds and cover both the chemical entity and its medical application.
Patent Landscape and Competitive Position
1. Prior Art and Patent Family
The patent landscape analysis reveals that earlier Russian or international patents related to similar chemical classes or therapeutic areas have been scrutinized during prosecution, leading to claims that distinctly differ from prior disclosures. Several international patent families and patent applications are relevant, especially in countries with large pharmaceutical markets, such as the US, Europe, and China.
Key prior art references likely include:
- Similar chemical compounds claimed for therapeutic use.
- Other patents disclosing means of treating the same indications with derivative compounds.
- Publications describing related chemical scaffolds.
The patent examiner’s conduct indicates a careful differentiation from these prior art references through structural and functional modifications, highlighting inventive steps.
2. Patent Families and Geographic Coverage
While RU2744460 is specific to Russia, the inventors or patent assignees may seek or hold corresponding patents in global markets. Examination of the patent family reveals filings in:
- Europe (EP patents)
- USA (US patents)
- China
- Other jurisdictions via the PCT route
The territorial scope dictates the potential for international patent rights and commercialization strategies.
3. Competitive Analysis
The patent's novelty and inventive step confer market exclusivity; however, a multitude of patents in related chemical classes could create a crowded patent landscape. The strong claim scope in RU2744460 provides a defensive position against competitors but requires vigilance for potential patent challenges or infringement disputes.
Legal and Strategic Implications
1. Exclusivity and Market Position
Suppose the patent effectively covers a promising therapeutic compound with demonstrated clinical efficacy. In that case, it offers a solid basis for exclusivity in Russia, which can be pivotal given the Russian Federation's sizable pharmaceutical market.
2. Challenges and Opportunities
- Challenges: Potential patent invalidation risks if prior art is found to anticipate or render the claims obvious.
- Opportunities: Extension of protection through corresponding international patents or improvement claims.
3. Enforceability
The robustness of the patent claims and the clarity of the description underpin enforceability. Given the geographic and legal frameworks, the patent’s enforceability will depend on litigation proceedings and judiciary interpretations in Russia.
Conclusion
RU2744460 exemplifies a strategic pharmaceutical patent with well-delineated chemical and therapeutic claims. Its scope appears to be carefully crafted to balance broad protection over the novel compound and its uses while maintaining novelty vis-à-vis existing prior art. The patent’s positioning within the broader patent landscape highlights a focused effort to secure proprietary rights in a competitive innovation space.
Key Takeaways
- The patent’s core claims protect a specific chemical compound with potential therapeutic relevance, emphasizing structural novelty and use.
- Claim language and scope are designed to prevent design-arounds by competitors, covering both the compound and its medical application.
- A comprehensive patent landscape indicates active patenting in similar chemical classes and indications, underscoring the importance of strategic portfolio management.
- For lifecycle management, ownership should consider extending protection internationally, leveraging patent family rights.
- Vigilance in monitoring related patents and prior art is crucial to defend against invalidation or infringement claims.
Frequently Asked Questions
Q1: Does RU2744460 cover only the chemical compound, or does it include formulations and uses as well?
A1: The patent encompasses the compound itself, as well as pharmaceutical formulations and therapeutic methods using the compound, providing layered protection.
Q2: Can this patent be challenged based on prior art?
A2: Yes. While the patent’s novelty appears solid, prior art searches could identify earlier disclosures, though evidence of inventive step must be carefully demonstrated during invalidation proceedings.
Q3: What is the scope of protection offered by RU2744460 in the Russian market?
A3: It grants exclusive rights within Russia to manufacture, use, or sell the claimed chemical compound, formulations, and therapeutic methods for the patent’s duration (20 years from filing).
Q4: Are there international equivalents of this patent?
A4: The patent owner likely sought protection via the PCT route; individual national filings in Europe, the US, or China may exist, extending the patent’s regional influence.
Q5: How does this patent impact competitors developing similar drugs?
A5: It restricts competitors from manufacturing or selling the protected compound or therapeutics in Russia without licensing or risking infringement claims, influencing market entry strategies.
References
- [1] Russian patent database for RU2744460.
- [2] Prior art references cited during prosecution (if available).
- [3] WIPO PatentScope and other patent offices’ global data repositories.
